Your browser doesn't support javascript.
loading
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma.
Li, Ziduo; Ju, Xinsheng; Lee, Kenneth; Clarke, Candice; Hsu, Jennifer L; Abadir, Edward; Bryant, Christian E; Pears, Suzanne; Sunderland, Neroli; Heffernan, Scott; Hennessy, Annemarie; Lo, Tsun-Ho; Pietersz, Geoffrey A; Kupresanin, Fiona; Fromm, Phillip D; Silveira, Pablo A; Tsonis, Con; Cooper, Wendy A; Cunningham, Ilona; Brown, Christina; Clark, Georgina J; Hart, Derek N J.
Afiliação
  • Li Z; Dendritic Cell Research, ANZAC Research Institute, Sydney, Australia.
  • Ju X; Sydney Medical School, University of Sydney, Australia.
  • Lee K; Dendritic Cell Research, ANZAC Research Institute, Sydney, Australia xinsheng.ju@sydney.edu.au.
  • Clarke C; Sydney Medical School, University of Sydney, Australia.
  • Hsu JL; Sydney Medical School, University of Sydney, Australia.
  • Abadir E; Department of Anatomical Pathology, Concord Repatriation General Hospital, Sydney, Australia.
  • Bryant CE; Department of Anatomical Pathology, Concord Repatriation General Hospital, Sydney, Australia.
  • Pears S; Dendritic Cell Research, ANZAC Research Institute, Sydney, Australia.
  • Sunderland N; Sydney Medical School, University of Sydney, Australia.
  • Heffernan S; Dendritic Cell Research, ANZAC Research Institute, Sydney, Australia.
  • Hennessy A; Sydney Medical School, University of Sydney, Australia.
  • Lo TH; Dendritic Cell Research, ANZAC Research Institute, Sydney, Australia.
  • Pietersz GA; Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Kupresanin F; Animal Facility, Royal Prince Alfred Hospital, Sydney, Australia.
  • Fromm PD; Animal Facility, Royal Prince Alfred Hospital, Sydney, Australia.
  • Silveira PA; Animal Facility, Royal Prince Alfred Hospital, Sydney, Australia.
  • Tsonis C; Animal Facility, Royal Prince Alfred Hospital, Sydney, Australia.
  • Cooper WA; Dendritic Cell Research, ANZAC Research Institute, Sydney, Australia.
  • Cunningham I; Sydney Medical School, University of Sydney, Australia.
  • Brown C; Burnet Institute, Melbourne, Australia.
  • Clark GJ; Baker Heart and Diabetes Institute, Melbourne, Australia.
  • Hart DNJ; Dendritic Cell Research, ANZAC Research Institute, Sydney, Australia.
Haematologica ; 103(4): 655-665, 2018 04.
Article em En | MEDLINE | ID: mdl-29351987

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulinas / Doença de Hodgkin / Glicoproteínas de Membrana / Biomarcadores Tumorais / Antígenos CD / Terapia de Alvo Molecular Tipo de estudo: Diagnostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulinas / Doença de Hodgkin / Glicoproteínas de Membrana / Biomarcadores Tumorais / Antígenos CD / Terapia de Alvo Molecular Tipo de estudo: Diagnostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2018 Tipo de documento: Article